The metabolic score for insulin resistance index is associated with myocardial ischemia, with non-alcoholic fatty liver disease serving as an important bridge

Tian Yu, Fan Sun, Wenji Yu, Feifei Zhang, Jianfeng Wang, Xiaoliang Shao, Bao Liu, Xiaoyu Yang, Yongjun Chen, Sijin Li, Yuetao WangFrontiers in Endocrinology 2025 · DOI

TL;DR

This study identifies the Metabolic Score for Insulin Resistance (METS-IR) as a powerful predictor of myocardial ischemia (restricted blood flow to the heart). Crucially, the researchers used mediation analysis to reveal that this relationship isn't direct; instead, Non-Alcoholic Fatty Liver Disease (NAFLD) acts as a "complete mediator," serving as the essential biological bridge between systemic insulin resistance and heart tissue starvation.

What Problem Does This Paper Address?

Insulin resistance (IR) is a well-known precursor to type 2 diabetes and cardiovascular disease, but measuring it accurately in a clinical setting is difficult. The "gold standard" (the hyperinsulinemic-euglycemic clamp) is invasive and expensive. While simpler proxies like METS-IR—which uses common metrics like BMI and cholesterol—have emerged, we still don't fully understand the mechanical pathway through which these metabolic signals translate into physical damage to the heart.

The authors set out to determine if METS-IR could predict myocardial ischemia (detected via advanced imaging) and, more importantly, whether the liver plays a starring role in that process. They specifically looked at NAFLD, a condition where excess fat builds up in the liver, to see if it is the "missing link" connecting metabolic dysfunction to cardiac distress.

Methods

The researchers conducted a retrospective cohort study of 1,242 patients with suspected coronary artery disease. To ensure high-quality data, they narrowed the group down to 335 participants who had complete records and recent imaging.

The study utilized two primary high-tech imaging modalities:

  • SPECT-MPI (Single-Photon Emission Computed Tomography): Used to identify myocardial ischemia by measuring blood flow to the heart during stress and rest.
  • CT Imaging: Used to diagnose NAFLD by calculating the liver-to-spleen density ratio.

The "secret sauce" of the paper is the mediation analysis. This statistical technique allows researchers to determine if the effect of an independent variable (METS-IR) on a dependent variable (ischemia) is direct or if it flows through an intermediate "mediator" (NAFLD).

Datasets

The study used a clinical dataset from the Third Affiliated Hospital of Soochow University, covering patients seen between January 2022 and December 2024.

  • Initial Pool: 1,242 patients.
  • Final Study Population: 335 patients (56.1% men, mean age ~61 years).
  • Key Metrics Collected: Fasting blood glucose (FBG), triglycerides (TG), HDL-cholesterol, BMI, and coronary artery calcium scores (CACS).

Key Insights and Ideas

  • The "Complete Mediator" Discovery: The most striking finding is that NAFLD is a complete mediator. In statistical terms, once you account for the presence of fatty liver disease, the direct correlation between the METS-IR score and heart ischemia effectively disappears. This suggests that insulin resistance primarily damages the heart by way of the liver.
  • The Liver as a Metabolic Hub: The paper proposes a biological "domino effect": High insulin resistance leads to fat deposition in the liver. This "fatty liver" then triggers a flood of free fatty acids and inflammatory cytokines (like TNF-α and IL-6) into the bloodstream, which ultimately impairs the heart's ability to use energy and maintain blood flow.
  • Utility of Non-Insulin Scores: The study reinforces that METS-IR—a score that requires no actual insulin measurement—is a highly effective tool for identifying high-risk cardiac patients. This makes it far more practical for routine clinical use than traditional insulin-based tests.

Key Results

  • Ischemia Prevalence: 53.4% of the study participants were found to have myocardial ischemia via SPECT-MPI.
  • Initial Risk: In a simple model, every standard deviation increase in the METS-IR score was associated with a 3.92x increase in the odds of having myocardial ischemia (OR 3.92; 95% CI: 1.38-11.08).
  • The Mediation Effect: The mediation analysis showed a significant indirect effect (0.292, p < 0.001) through NAFLD, while the direct effect of METS-IR on the heart became statistically insignificant (0.027, p = 0.84) when NAFLD was included in the model.
  • NAFLD Association: METS-IR was extremely strongly associated with the presence of NAFLD (OR 20.23 in the fully adjusted model).

Limitations and Future Work

The authors acknowledge several hurdles:

  • Retrospective Design: Because the data was collected after the fact, the study can show strong associations but cannot definitively prove that METS-IR causes NAFLD, which then causes ischemia.
  • Single-Center Study: The data comes from one hospital in China, which may limit how well these findings apply to other global populations.
  • Confounding Variables: While they adjusted for many factors, the researchers did not specifically account for the long-term effects of certain medications (like statins or fibrates) that might influence both liver fat and heart health.

Future Work: The authors suggest longitudinal studies (tracking patients over many years) to confirm the "bridge" theory and exploring whether treating NAFLD directly can reduce the risk of heart ischemia in patients with high insulin resistance.

Summary updated

Abstract

This study provides evidence for the relationship between METS-IR and myocardial ischemia and highlights the important mediating role of NAFLD in this relationship.
BibTeX
@inproceedings{yu2025metabolic,
  author = {Tian Yu and Fan Sun and Wenji Yu and Feifei Zhang and Jianfeng Wang and Xiaoliang Shao and Bao Liu and Xiaoyu Yang and Yongjun Chen and Sijin Li and Yuetao Wang},
  title = {{The metabolic score for insulin resistance index is associated with myocardial ischemia, with non-alcoholic fatty liver disease serving as an important bridge}},
  booktitle = {Frontiers in Endocrinology},
  year = {2025},
  doi = {10.3389/fendo.2025.1592463},
}
Figure